Small Cap Equities

ESG in Pharma: Has the ‘S’ Reached a Turning Point?

Increased regulation and heightened competition are transforming the pharma industry’s behavior when it comes to the pricing and availability of medicine.

ESG in Smaller Companies: An Overlooked Opportunity?

When it comes to ESG, smaller companies have their own unique challenges—which can also provide opportunities for active managers to identify unrecognized growth and undervalued companies.

Three Reasons to Consider a Long-Term Allocation to Small-Caps

The volatility driven by COVID-19 and the fall in oil prices has created much uncertainty—but it has also provided a potential opportunity to make long-term investments at attractive prices.